Diagnostics

Adial Pharmaceuticals files a key patent to protect its personalized Alcohol Use Disorder drug, AD04, until 2045, signaling a new era for addiction medicine.

VideaHealth launches AutoVerify, an AI tool to automate insurance checks, promising to slash claim denials, speed up payments, and build patient trust.

As BD enters a new growth phase with interim leadership, the MedTech giant brings in Shawn Bevec, whose unique background bridges lab science and Wall Street.

The company reports major clinical trial progress for Duchenne, FA, and CPVT, while its next-gen capsid technology gains widespread industry adoption.

A massive settlement for a child poisoned by lead paint reveals a landlord's neglect and exposes a city's ongoing battle with a silent, toxic epidemic.

The biopharma firm projects massive sales from its current drugs and bets big on a new Alzheimer's therapy, signaling a pivotal year of growth and innovation.

WNBA star Erica Wheeler lost her mom to cervical cancer. Now, she's teaming up with Hologic to tackle a worrying rise in cases and save lives.

Propanc Biopharma is taking a 100-year-old cancer treatment concept into modern human trials, targeting advanced tumors and expanding into fibrosis.

A new partnership aims to tackle the growing global health crisis of invasive fungal infections, a silent killer claiming millions of lives annually.

Two industry giants are teaming up to build the autonomous labs of tomorrow, promising to revolutionize scientific discovery at an unprecedented scale.

With new federal guidelines backing whole foods, programs delivering 'prescription produce' are proving they can cut healthcare costs and fight chronic disease.

A new drill-free cavity treatment is regenerating teeth, attracting Wall Street, and aiming to solve a global health crisis. This is the story of Curodont™.

A new video shows Vitestro's Aletta® robot drawing blood. Can this AI-powered device solve staffing shortages and improve patient care worldwide?

A tech firm is leveraging sound waves to overcome key hurdles in brain-computer interfaces, paving the way for advanced rehabilitation and assistive care.

As cyber threats in healthcare escalate, CIVIE's HITRUST e1 certification signals a new standard for patient data protection in AI-driven medical tech.

Avalon GloboCare regains Nasdaq compliance, but its future is being reshaped by a bold AI launch and a transformative merger that questions its identity.

With $6.5M CAD in new funding, Montréal's AI4Eyes is set to accelerate the global launch of its all-in-one diagnostic and treatment platform.

NYU Langone and tech firm Tempus are launching a new protocol using serial DNA sequencing and AI to create hyper-personalized cancer treatments.

For the 24th straight year, nurses top Gallup's ethics poll, but this enduring trust masks a profession in crisis, battling burnout and staff shortages.

A major new partnership is racing to deploy predictive tech, from blood tests to eye scans, to prevent millions of stillbirths in years, not decades.